IGC PHARMA INC (IGC)

US45408X3089 - Common Stock

0.427  -0.01 (-2.73%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025
Revenue
YoY % growth
900K
-77.89%		400K
-55.56%		910K
127.50%		1.255M
37.91%
EBITDA
YoY % growth
-8.24M
-22.44%		-10.03M
-21.72%		-10.53M
-4.99%		N/AN/A
EBIT
YoY % growth
-8.72M
-26.93%		-10.68M
-22.48%		-11.19M
-4.78%		-10.415M
6.92%
Operating Margin
-968.89%-2,670.00%-1,229.67%-829.89%
EPS
YoY % growth
N/AN/AN/A-0.22

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.04
Revenue
Q2Q % growth		194.93K
14.66%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-2.711M
25.93%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% N/A 0% N/A
Revenue0% N/A 0% N/A